Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense, Denmark.
Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark.
Cardiovasc Diabetol. 2021 Sep 8;20(1):182. doi: 10.1186/s12933-021-01375-7.
Basement membrane (BM) accumulation is a hallmark of micro-vessel disease in diabetes mellitus (DM). We previously reported marked upregulation of BM components in internal thoracic arteries (ITAs) from type 2 DM (T2DM) patients by mass spectrometry. Here, we first sought to determine if BM accumulation is a common feature of different arteries in T2DM, and second, to identify other effects of T2DM on the arterial proteome.
Human arterial samples collected during heart and vascular surgery from well-characterized patients and stored in the Odense Artery Biobank were analysed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). We included ascending thoracic aortas (ATA) (n = 10 (type 2 DM, T2DM) and n = 10 (non-DM)); laser capture micro-dissected plaque- and media compartments from carotid plaques (n = 10 (T2DM) and n = 9 (non-DM)); and media- and adventitia compartments from ITAs (n = 9 (T2DM) and n = 7 (non-DM)).
We first extended our previous finding of BM accumulation in arteries from T2DM patients, as 7 of 12 pre-defined BM proteins were significantly upregulated in bulk ATAs consisting of > 90% media. Although less pronounced, BM components tended to be upregulated in the media of ITAs from T2DM patients, but not in the neighbouring adventitia. Overall, we did not detect effects on BM proteins in carotid plaques or in the plaque-associated media. Instead, complement factors, an RNA-binding protein and fibrinogens appeared to be regulated in these tissues from T2DM patients.
Our results suggest that accumulation of BM proteins is a general phenomenon in the medial layer of non-atherosclerotic arteries in patients with T2DM. Moreover, we identify additional T2DM-associated effects on the arterial proteome, which requires validation in future studies.
基底膜(BM)积累是糖尿病(DM)中小血管疾病的一个标志。我们之前通过质谱法报道了 2 型糖尿病(T2DM)患者的内胸动脉(ITA)中 BM 成分的显著上调。在这里,我们首先试图确定 BM 积累是否是 T2DM 中不同动脉的共同特征,其次,确定 T2DM 对动脉蛋白质组的其他影响。
从特征明确的患者心脏和血管手术中收集的人类动脉样本,并储存在奥登塞动脉生物库中,通过液相色谱与串联质谱(LC-MS/MS)进行分析。我们包括升主动脉(ATA)(n=10(2 型糖尿病,T2DM)和 n=10(非糖尿病));颈动脉斑块的激光捕获微切割斑块和中层(n=10(T2DM)和 n=9(非糖尿病));和 ITAs 的中层和外膜(n=9(T2DM)和 n=7(非糖尿病))。
我们首先扩展了我们之前在 T2DM 患者动脉中发现的 BM 积累的发现,因为 12 个预先定义的 BM 蛋白中有 7 个在由>90%中层组成的大块 ATAs 中显著上调。尽管不那么明显,但 T2DM 患者的 ITAs 中层中的 BM 成分也有上调趋势,但外膜中没有。总的来说,我们没有在颈动脉斑块或斑块相关的中层中检测到 BM 蛋白的影响。相反,补体因子、一种 RNA 结合蛋白和纤维蛋白原似乎在这些组织中受到 T2DM 患者的调节。
我们的结果表明,BM 蛋白的积累是 T2DM 患者非动脉粥样硬化动脉中层的普遍现象。此外,我们确定了动脉蛋白质组中与 T2DM 相关的其他影响,这需要在未来的研究中进行验证。